BTA | HYMB | BTA / HYMB | |
Gain YTD | -6.219 | -3.076 | 202% |
Net Assets | 127M | 2.62B | 5% |
Total Expense Ratio | 1.73 | 0.35 | 494% |
Turnover | 22.00 | 7.00 | 314% |
Yield | 5.04 | 4.51 | 112% |
Fund Existence | 19 years | 14 years | - |
BTA | HYMB | |
---|---|---|
RSI ODDS (%) | 2 days ago90% | 2 days ago60% |
Stochastic ODDS (%) | 2 days ago88% | 2 days ago45% |
Momentum ODDS (%) | 2 days ago64% | 2 days ago37% |
MACD ODDS (%) | 2 days ago73% | 2 days ago44% |
TrendWeek ODDS (%) | 2 days ago77% | 2 days ago55% |
TrendMonth ODDS (%) | 2 days ago76% | 2 days ago53% |
Advances ODDS (%) | 2 days ago83% | 8 days ago62% |
Declines ODDS (%) | 6 days ago82% | 2 days ago56% |
BollingerBands ODDS (%) | 2 days ago72% | 2 days ago51% |
Aroon ODDS (%) | 2 days ago83% | 2 days ago55% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
NSGAX | 23.16 | N/A | N/A |
Columbia Select Large Cap Equity A | |||
TLARX | 12.11 | N/A | N/A |
Transamerica Large Core ESG R | |||
FCUCX | 19.67 | -0.08 | -0.41% |
NYLI PineStone U.S. Equity Class C | |||
HFQDX | 6.92 | -0.07 | -1.00% |
Janus Henderson Global Equity Income D | |||
SHPAX | 19.12 | -0.24 | -1.24% |
Saratoga Health & Biotechnology A |